SSE PLC (SSE)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 2,505.00 |
|---|---|
| 52-week range | 1,791.17 – 2,715.76 |
| Return, 1 month / 3 months | +3.0% / +4.2% |
| Return, 1 year / 3 years | +37.7% / +76.2% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 5,930.49M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SSE is an energy company based in Scotland that produces and supplies electricity and gas to homes and businesses across the United Kingdom and Ireland. It runs electricity transmission and distribution networks, generates power from renewable sources such as wind, and provides retail energy and related services to household and business customers. The company also offers energy-efficiency and metering services and develops new renewable generation projects.
On this site SSE PLC appears as a stock on the London Exchange (UK), code SSE, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SSE PLC (SSE) trades on the London Exchange in UK. It last closed at GBX 2,505.00 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 871 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.7% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.7% | ||
| From 52-week high | -7.4% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | -1.2% | ||
| 12-month return, skipping the last month | 33.7% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 5,930.49M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +3.0% |
| 3 months | +4.2% |
| 6 months | −1.2% |
| 1 year | +37.7% |
| 3 years | +76.2% |
| 5 years | +89.3% |
Signals
| 50-day / 200-day average | 2,430.96 / 2,439.28 |
|---|---|
| Golden / death cross (60 days) | Death, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 56.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jul 2026 | GBP 0.4730 |
| 4 Dec 2025 | GBP 0.2140 |
| 24 Jul 2025 | GBP 0.4300 |
| 2 Jan 2025 | GBP 0.2120 |
| 25 Jul 2024 | GBP 0.4000 |
| 11 Jan 2024 | GBP 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.